Pacer Advisors Inc. Lowers Position in Encompass Health Corporation $EHC

Pacer Advisors Inc. decreased its stake in shares of Encompass Health Corporation (NYSE:EHC) by 93.1% in the first quarter, Holdings Channel.com reports. The fund owned 11,948 shares of the company’s stock after selling 160,088 shares during the period. Pacer Advisors Inc.’s holdings in Encompass Health were worth $1,156,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently bought and sold shares of EHC. Northwestern Mutual Wealth Management Co. boosted its holdings in shares of Encompass Health by 3,059,159.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,793,482 shares of the company’s stock valued at $402,640,000 after purchasing an additional 3,793,358 shares during the last quarter. Norges Bank bought a new stake in shares of Encompass Health in the fourth quarter worth about $133,221,000. Price T Rowe Associates Inc. MD lifted its position in shares of Encompass Health by 24.6% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 4,805,413 shares of the company’s stock worth $510,047,000 after buying an additional 948,202 shares in the last quarter. Millennium Management LLC boosted its stake in Encompass Health by 140.0% during the third quarter. Millennium Management LLC now owns 1,223,665 shares of the company’s stock valued at $155,430,000 after buying an additional 713,738 shares during the last quarter. Finally, 8 Knots Management LLC bought a new position in Encompass Health during the second quarter valued at approximately $78,644,000. 97.25% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

EHC has been the topic of a number of research reports. Weiss Ratings downgraded Encompass Health from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, June 26th. UBS Group raised their target price on shares of Encompass Health from $150.00 to $155.00 and gave the company a “buy” rating in a report on Friday. Truist Financial boosted their price target on shares of Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a research report on Friday. Wall Street Zen downgraded shares of Encompass Health from a “buy” rating to a “hold” rating in a research note on Saturday. Finally, TD Cowen began coverage on shares of Encompass Health in a research report on Thursday, May 28th. They set a “buy” rating and a $125.00 price objective for the company. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Encompass Health has an average rating of “Moderate Buy” and a consensus price target of $146.57.

Encompass Health Trading Up 0.1%

Shares of NYSE EHC opened at $125.39 on Monday. Encompass Health Corporation has a 1-year low of $92.77 and a 1-year high of $127.99. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.19 and a quick ratio of 1.17. The business’s 50 day moving average is $106.91 and its two-hundred day moving average is $104.62. The stock has a market capitalization of $12.44 billion, a P/E ratio of 20.42, a PEG ratio of 2.52 and a beta of 0.72.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.48 by $0.07. The business had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.57 billion. Encompass Health had a return on equity of 18.08% and a net margin of 10.01%.The company’s revenue for the quarter was up 9.6% on a year-over-year basis. During the same period last year, the company earned $1.40 EPS. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. As a group, research analysts expect that Encompass Health Corporation will post 6.07 EPS for the current year.

Encompass Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be paid a dividend of $0.21 per share. The ex-dividend date of this dividend is Thursday, October 1st. This is a positive change from Encompass Health’s previous quarterly dividend of $0.19. This represents a $0.84 annualized dividend and a yield of 0.7%. Encompass Health’s payout ratio is presently 12.38%.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.